Abstract [Download PDF] [Read Full Text]
Low-concentration atropine sulfate eye drop has been increasingly used to control the progression of myopia in children.At present, most of the domestic low-concentration atropine eye drops are nosocomial preparations, and there is no unified standard for each preparation, which brings lots of uncertainty for the effectiveness and safety assessment.It is necessary to standardize the hospital preparation of low-concentration atropin products.In order to ensure the clinical treatment effect and safety of low-concentration atropine, in view of the key points in the preparation of low-concentration atropine ophthalmic preparations, initiated by Shanghai Eye Disease Prevention and Control Center/Shanghai Eye Hospital, the Standing Committee of the Shanghai Medical Association Optometry Branch, the Hospital Preparation Group of the Pharmacy Special Committee of Shanghai Pharmaceutical Association Hospital, and well-known domestic ophthalmology and pharmaceutical experts, an Experts consensus on preparation of low-concentration atropine sulfate for myopia progression control (2023) was formulated for the reference and application of ophthalmologists, pharmacy workers and users of ophthalmic low-concentration atropine sulfate preparations.